Cardiac Cell-specific Apoptotic and Cytokine Responses to Reovirus Infection: Determinants of Myocarditic Phenotype

Journal of Cardiac Failure

Volumn 15, Issue 6, 2009, Pages 529-539

  Miyamoto, Shelley D ^a   Brown, R D ^a   Robinson, Bridget A ^a   Tyler, Kenneth L ^a,c   Long, Carlin S ^a   Debiasi, Roberta L ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

fibroblasts; myocytes; Viral myocarditis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOMETRY; FIBROBLAST; HEART MUSCLE CELL; MOUSE; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; REOVIRUS; SUPERNATANT; VIRUS INFECTION; VIRUS MYOCARDITIS; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELLS, CULTURED; CYTOKINES; MYOCARDITIS; MYOCYTES, CARDIAC; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; REOVIRIDAE INFECTIONS;

EID: 67651030809     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.01.004     Document Type: Article

References (71)

1. Feldman A.M., and McNamara D. Myocarditis. N Engl J Med 343 (2000) 1388-1398
2. Mason J.W. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 60 (2003) 5-10
3. Kuhl U., Pauschinger M., Seeberg B., Lassner D., Noutsias M., Poller W., et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112 (2005) 1965-1970
4. Lauer B., Schannwell M., Kuhl U., Strauer B.E., and Schultheiss H.P. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 35 (2000) 11-18
5. Nishii M., Inomata T., Takehana H., Takeuchi I., Nakano H., Koitabashi T., et al. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol 44 (2004) 1292-1297
6. Sheppard R., Bedi M., Kubota T., Semigran M.J., Dec W., Holubkov R., et al. Myocardial expression of fas and recovery of left ventricular function in patients with recent-onset cardiomyopathy. J Am Coll Cardiol 46 (2005) 1036-1042
7. Yamamoto K., Shioi T., Uchiyama K., Miyamoto T., Sasayama S., and Matsumori A. Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice. J Am Coll Cardiol 42 (2003) 2000-2006
8. Aretz H.T., Billingham M.E., Edwards W.D., Factor S.M., Fallon J.T., Fenoglio Jr. J.J., et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1 (1987) 3-14
9. Baughman K.L. Diagnosis of myocarditis: death of Dallas criteria. Circulation 113 (2006) 593-595
10. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 99 (1999) 1091-1100
11. Liu P.P., and Mason J.W. Advances in the understanding of myocarditis. Circulation 104 (2001) 1076-1082
12. Huber S. Cellular autoimmunity in myocarditis. Heart Fail Clin 1 (2005) 321-331
13. Sherry B., Baty C.J., and Blum M.A. Reovirus-induced acute myocarditis in mice correlates with viral RNA synthesis rather than generation of infectious virus in cardiac myocytes. J Virol 70 (1996) 6709-6715
14. Spandidos D.A., and Graham A.F. Generation of defective virus after infection of newborn rats with reovirus. J Virol 20 (1976) 234-247
15. Bennette J.G., Bush P.V., and Steele R.D. Characteristics of a newborn runt disease induced by neonatal infection with an oncolytic strain of reovirus type 3 (REO3MH). II. Immunological aspects of the disease in mice. Br J Exp Pathol 48 (1967) 267-284
16. Kilham L., and Margolis G. Hydrocephalus in hamsters, ferrets, rats, and mice following inoculations with reovirus type I.I. Virologic studies. Lab Invest 21 (1969) 183-188
17. Lussier G., and Descoteaux J.P. Prevalence of natural virus infections in laboratory mice and rats used in Canada. Lab Anim Sci 36 (1986) 145-148
18. Farone A.L., Frevert C.W., Farone M.B., Morin M.J., Fields B.N., Paulauskis J.D., et al. Serotype-dependent induction of pulmonary neutrophilia and inflammatory cytokine gene expression by reovirus. J Virol 70 (1996) 7079-7084
19. Morin M.J., Warner A., and Fields B.N. Reovirus infection in rat lungs as a model to study the pathogenesis of viral pneumonia. J Virol 70 (1996) 541-548
20. DeBiasi R.L., Edelstein C.L., Sherry B., and Tyler K.L. Calpain inhibition protects against virus-induced apoptotic myocardial injury. J Virol 75 (2001) 351-361
21. DeBiasi R.L., Robinson B.A., Sherry B., Bouchard R., Brown R.D., Rizeq M., et al. Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol 78 (2004) 11040-11050
22. Debiasi R.L., Squier M.K., Pike B., Wynes M., Dermody T.S., Cohen J.J., et al. Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors. J Virol 73 (1999) 695-701
23. Sherry B. Pathogenesis of reovirus myocarditis. Curr Top Microbiol Immunol 233 (1998) 51-66
24. Sherry B., and Blum M.A. Multiple viral core proteins are determinants of reovirus-induced acute myocarditis. J Virol 68 (1994) 8461-8465
25. Sherry B., and Fields B.N. The reovirus M1 gene, encoding a viral core protein, is associated with the myocarditic phenotype of a reovirus variant. J Virol 63 (1989) 4850-4856
26. Sherry B., Schoen F.J., Wenske E., and Fields B.N. Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol 63 (1989) 4840-4849
27. Baty C.J., and Sherry B. Cytopathogenic effect in cardiac myocytes but not in cardiac fibroblasts is correlated with reovirus-induced acute myocarditis. J Virol 67 (1993) 6295-6298
28. Hassan S.A., Rabin E.R., and Melnick J.L. Reovirus myocarditis in mice: an electron microscopic, immunofluorescent, and virus assay study. Exp Mol Pathol 76 (1965) 66-80
29. Sherry B., Li X.Y., Tyler K.L., Cullen J.M., and Virgin H.W.T. Lymphocytes protect against and are not required for reovirus-induced myocarditis. J Virol 67 (1993) 6119-6124
30. Bowles N.E., Ni J., Kearney D.L., Pauschinger M., Schultheiss H.P., McCarthy R., et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42 (2003) 466-472
31. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
32. Nakamura M., Wang N.P., Zhao Z.Q., Wilcox J.N., Thourani V., Guyton R.A., et al. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res 45 (2000) 661-670
33. Kyto V., Saraste A., Saukko P., Henn V., Pulkki K., Vuorinen T., et al. Apoptotic cardiomyocyte death in fatal myocarditis. Am J Cardiol 94 (2004) 746-750
34. Kyto V., Lapatto R., Lakkisto P., Saraste A., Voipio-Pulkki L.M., Vuorinen T., et al. Glutathione depletion and cardiomyocyte apoptosis in viral myocarditis. Eur J Clin Invest 34 (2004) 167-175
35. Colston J.T., Chandrasekar B., and Freeman G.L. Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis. Cardiovasc Res 38 (1998) 158-168
36. Saraste A., Arola A., Vuorinen T., Kyto V., Kallajoki M., Pulkki K., et al. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovasc Pathol 12 (2003) 255-262
37. Joo C.H., Hong H.N., Kim E.O., Im J.O., Yoon S.Y., Ye J.S., et al. Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains. Intervirology 46 (2003) 135-140
38. Stewart M.J., Smoak K., Blum M.A., and Sherry B. Basal and reovirus-induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expression are cell type specific in the cardiac protective response. J Virol 79 (2005) 2979-2987
39. Stewart M.J., Blum M.A., and Sherry B. PKR's protective role in viral myocarditis. Virology 314 (2003) 92-100
40. Long C.S., and Brown R.D. The cardiac fibroblast, another therapeutic target for mending the broken heart?. J Mol Cell Cardiol 34 (2002) 1273-1278
41. Brown R.D., Ambler S.K., Mitchell M.D., and Long C.S. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45 (2005) 657-687
42. Sherry B., Torres J., and Blum M.A. Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins. J Virol 72 (1998) 1314-1323
43. Long C.S., Henrich C.J., and Simpson P.C. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Regul 2 (1991) 1081-1095
44. Koudssi F., Lopez J.E., Villegas S., and Long C.S. Cardiac fibroblasts arrest at the G1/S restriction point in response to interleukin (IL)-1beta. Evidence for IL-1beta-induced hypophosphorylation of the retinoblastoma protein. J Biol Chem 273 (1998) 25796-25803
45. Tyler K.L., Bronson R.T., Byers K.B., and Fields B. Molecular basis of viral neurotropism: experimental reovirus infection. Neurology 35 (1985) 88-92
46. Kinugawa K., Minobe W.A., Wood W.M., Ridgway E.C., Baxter J.D., Ribeiro R.C., et al. Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression. Circulation 103 (2001) 1089-1094
47. Patten M., Hartogensis W.E., and Long C.S. Interleukin-1beta is a negative transcriptional regulator of alpha1-adrenergic induced gene expression in cultured cardiac myocytes. J Biol Chem 271 (1996) 21134-21141
48. Shioi T., Matsumori A., and Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 94 (1996) 2930-2937
49. Long C.S. The role of interleukin-1 in the failing heart. Heart Fail Rev 6 (2001) 81-94
50. Yue P., Massie B.M., Simpson P.C., and Long C.S. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol 275 (1998) H250-H258
51. Kajstura J., Zhang X., Reiss K., Szoke E., Li P., Lagrasta C., et al. Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res 74 (1994) 383-400
52. Yamauchi-Takihara K., Ihara Y., Ogata A., Yoshizaki K., Azuma J., and Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 91 (1995) 1520-1524
53. Turner N.A., Mughal R.S., Warburton P., O'Regan D.J., Ball S.G., and Porter K.E. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. Cardiovasc Res 76 (2007) 81-90
54. Lim B.K., Choe S.C., Shin J.O., Ho S.H., Kim J.M., Yu S.S., et al. Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis. Circulation 105 (2002) 1278-1281
55. Kanda T., McManus J.E., Nagai R., Imai S., Suzuki T., Yang D., et al. Modification of viral myocarditis in mice by interleukin-6. Circ Res 78 (1996) 848-856
56. Nishio R., Matsumori A., Shioi T., Ishida H., and Sasayama S. Treatment of experimental viral myocarditis with interleukin-10. Circulation 100 (1999) 1102-1108
57. Kanda T., Tanaka T., Sekiguchi K., Seta Y., Kurimoto M., Wilson McManus J.E., et al. Effect of interleukin-18 on viral myocarditis: enhancement of interferon- gamma and natural killer cell activity. J Mol Cell Cardiol 32 (2000) 2163-2171
58. Azzam-Smoak K., Noah D.L., Stewart M.J., Blum M.A., and Sherry B. Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis. Virology 298 (2002) 20-29
59. Noah D.L., Blum M.A., and Sherry B. Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte cultures. J Virol 73 (1999) 10208-10213
60. Brown R.D. A.M., Polizzi S.M., and Long C.S. Cytokines regulate inflammatory and fibrotic gene programs in rat cardiac fibroblasts. [abstract]. FASEB J 17 (2003) A1359
61. Felker G.M., Thompson R.E., Hare J.M., Hruban R.H., Clemetson D.E., Howard D.L., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342 (2000) 1077-1084
62. Dec Jr. G.W., Palacios I.F., Fallon J.T., Aretz H.T., Mills J., Lee D.C., et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 312 (1985) 885-890
63. Ardehali H., Kasper E.K., and Baughman K.L. Diagnostic approach to the patient with cardiomyopathy: whom to biopsy. Am Heart J 149 (2005) 7-12
64. Martin A.B., Webber S., Fricker F.J., Jaffe R., Demmler G., Kearney D., et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 90 (1994) 330-339
65. Pauschinger M., Bowles N.E., Fuentes-Garcia F.J., Pham V., Kuhl U., Schwimmbeck P.L., et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99 (1999) 1348-1354
66. Why H.J., Meany B.T., Richardson P.J., Olsen E.G., Bowles N.E., Cunningham L., et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89 (1994) 2582-2589
67. Fujioka S., Kitaura Y., Ukimura A., Deguchi H., Kawamura K., Isomura T., et al. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 36 (2000) 1920-1926
68. Chan K.Y., Iwahara M., Benson L.N., Wilson G.J., and Freedom R.M. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. J Am Coll Cardiol 17 (1991) 458-460
69. Mason J.W., O'Connell J.B., Herskowitz A., Rose N.R., McManus B.M., Billingham M.E., et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333 (1995) 269-275
70. Parrillo J.E., Cunnion R.E., Epstein S.E., Parker M.M., Suffredini A.F., Brenner M., et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321 (1989) 1061-1068
71. Lieberman E.B., Hutchins G.M., Herskowitz A., Rose N.R., and Baughman K.L. Clinicopathologic description of myocarditis. J Am Coll Cardiol 18 (1991) 1617-1626